Review The SDS Document
DOWNLOADProduct Details
Formula
C12H17NO3
MW
223.27
Purity
>97%
Solubility (DMSO Mg/MI)
40
Storage (Powder)
3 Years -20°C
Storage (Solvent)
1 Year -80°C
Indication
N/A
Mode Of Action
inhibitor
Drug Status
Approved
Target Name
Prostaglandin G/H synthase 1 (COX-1)/Prostaglandin G/H synthase 2 (COX-2)
Research Area
DERMATOLOGY
Research Area Sub Group
Antiinflammatory
Pharmacology
ENZYMES
Pharmacology Area Sub Group
Synthase
Bio Chemical Notes
Bufexamac is a COX inhibitor for IFN-α release with EC50 of 8.9 μM.